Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sorio

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Journal of Chemotherapy (Florence, Italy)|June 2, 2006
Oral etoposide in elderly patients with advanced non small cell lung cancer: a clinical and pharmacological studyR Sorio, G Toffoli, D Crivellari, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2M E Gore, E Galligioni, C W Keen, et al.
Blood|December 15, 1995
The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemiasA Carbone, A Gloghini, V Zagonel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Natural killer (NK) and lymphokine activated killer (LAK) cell activity in patients (PTS) treated with flavone acetic acid (FAA)E Galligioni, M Quaia, A Spada, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Hodgkin's disease in patients with HIV infection and in the general population: comparison of clinicopathological features and survivalD Errante, V Zagonel, E Vaccher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Increasing 4'-epidoxorubicin and fixed ifosfamide doses plus granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a pilot studyS Frustaci, A Buonadonna, E Galligioni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patientsG Toffoli, R Sorio, P Aita, et al.
AIDS Research|January 1, 1986
HTLV-III infection among 315 intravenous drug abusers: seroepidemiological, clinical, and pathological findingsU Tirelli, E Vaccher, A Carbone, et al.
Haematologica|December 24, 1997
Pharmacology of chronic oral daily administration of idarubicinG Toffoli, R Sorio, P Aita, et al.
Chemotherapy|November 24, 1999
Interactions of antineoplastic chemotherapy with zidovudine pharmacokinetics in patients with HIV-related neoplasmsG Toffoli, D Errante, G Corona, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Journal of Chemotherapy (Florence, Italy)|June 2, 2006
Oral etoposide in elderly patients with advanced non small cell lung cancer: a clinical and pharmacological studyR Sorio, G Toffoli, D Crivellari, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2M E Gore, E Galligioni, C W Keen, et al.
Blood|December 15, 1995
The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemiasA Carbone, A Gloghini, V Zagonel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Natural killer (NK) and lymphokine activated killer (LAK) cell activity in patients (PTS) treated with flavone acetic acid (FAA)E Galligioni, M Quaia, A Spada, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Hodgkin's disease in patients with HIV infection and in the general population: comparison of clinicopathological features and survivalD Errante, V Zagonel, E Vaccher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Increasing 4'-epidoxorubicin and fixed ifosfamide doses plus granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a pilot studyS Frustaci, A Buonadonna, E Galligioni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patientsG Toffoli, R Sorio, P Aita, et al.
AIDS Research|January 1, 1986
HTLV-III infection among 315 intravenous drug abusers: seroepidemiological, clinical, and pathological findingsU Tirelli, E Vaccher, A Carbone, et al.
Haematologica|December 24, 1997
Pharmacology of chronic oral daily administration of idarubicinG Toffoli, R Sorio, P Aita, et al.
Chemotherapy|November 24, 1999
Interactions of antineoplastic chemotherapy with zidovudine pharmacokinetics in patients with HIV-related neoplasmsG Toffoli, D Errante, G Corona, et al.
Pageof 6